Florida Law Lowers Opioid Use for Acute Post-Op Pain

  A new controlled substance law in Florida has helped to decrease opioid prescriptions after outpatient surgery, according to a retrospective analysis at a large academic center. Full story.  
Topics:

Human Translingual Neurostimulation Alters Resting Brain Activity in High-Density EEG

 Abstract: Background: Despite growing evidence of a critical link between neuromodulation technologies and neuroplastic recovery, the underlying mechanisms of these technologies remain elusive. Read the details. &n...
Continue reading
Topics:

AAPM Issues Updated Position Statement on Research into the Use of Cannabinoids for Medical Purposes

​ More than 30 states as well as Washington D.C. have legalized cannabis for medical purposes, making it more accessible than ever before to patients throughout the country, including patients suffering from chronic pain...
Continue reading

AAPM Endorses Pain Management Task Force Final Report on Best Practices for Treatment of Pain

June 5, 2019, CHICAGO – The American Academy of Pain Medicine Board of Directors (AAPM) enthusiastically endorses the HHS Pain Management Best Practices Inter-Agency Task Force Final Report , which calls for a balanced, ...
Continue reading
Topics:

Can Tech 'Objectively' Assess Pain?

Some combination of data and machinery may, go the pronouncements of the tech world, do what millennia of humans have been unable to: accurately feel someone else's pain.  Full story.  

Trialing of ISS in Patients With CRPS

Brief Summary: This is a multi-center, prospective, open-label, single-arm, observational, feasibility study. The goal of this study is to determine the feasibility of intra-spinal stimulation with optimal paresthesia coverage therapy for chronic pain relief in patients with complex regional pain syndrome type I or causalgia. Up to 20 patients with intractable chronic severe limb pain associated with complex regional pain syndrome (CRPS) will be included in the study. A standard of care trial phase to test a subjects' response to Intraspinal-Optimal Stim therapy will be conducted during a 3 to 10-day period. Patients that obtain 50% or greater pain relief during the trial period will undergo permanent implantation of the device. Primary outcome will evaluate pain response at 3 months of therapy, based on NPRS pain score relative to baseline. Patients will be followed up for 6 months after the start of therapy.

Continue reading

In Lab, SLU Researchers Flip Pain Switch in Spinal Cord Cells

Facing an urgent need for safer and more effective therapies for those suffering from debilitating pain, Saint Louis University researchers are on a mission to find a non-narcotic off-switch for pain.  Full story. &...
Continue reading

Multiple Brain Regions Moderate and Link Depressive Mood and Pain

  Researchers at University of California San Diego School of Medicine have identified specific regions of the brain that drive, influence, and moderate depressive mood and its relationship to perceiving physical pa...
Continue reading
Topics:

Efficacy of Headache Treatment Using Radiofrequency Ablation

Despite the availability of therapies, many headache syndromes remain refractory to symptomatic treatment, achieving incomplete resolution of pain, and patients with chronic headaches often pursue nonpharmacologic treatm...
Continue reading

Targeted Muscle Reinnervation Reduces Limb Pain After Amputation

Patients undergoing the nerve preimplantation procedure had less pain than patients undergoing conventional amputations as measured by best, current, and residual pain scores. The nerve transplant group also experienced ...
Continue reading